Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Laparoscopic tumor nephrectomy].

G Janetschek1, H al-Zachrani, G Vrabec

  • 1Abteilung für Urologie, Krankenhaus der Elisabethinen, Fadingerstrasse 1, 4020 Linz/Osterreich. guenter.janetschek@elisabethinen.or.at

Der Urologe. Ausg. A
|May 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC.

Case reports in urology·2015
Same author

Laparoscopic adenomectomy versus Eraser laser enucleation of the prostate.

World journal of urology·2015
Same author

Tissue effects resulting from eraser laser enucleation of the prostate: in vivo investigation.

Urologia internationalis·2013
Same author

The use of mannitol in partial and live donor nephrectomy: an international survey.

World journal of urology·2012
Same author

[Partial nephrectomy - pro laparoscopy].

Der Urologe. Ausg. A·2012
Same author

[Retroperitoneal lymphadenectomy - pro laparoscopy].

Der Urologe. Ausg. A·2012
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Laparoscopic radical nephrectomy is a safe and effective treatment for early-stage renal cell carcinoma (RCC). This minimally invasive approach offers excellent surgical outcomes and promising oncologic control with low complication rates.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Laparoscopic surgery in urology initially focused on benign conditions.
  • Its application in malignant disease management was limited to diagnostics.
  • Recent advancements show promise for laparoscopy in treating low-stage renal cell carcinoma (RCC).

Purpose of the Study:

  • To present institutional experience with laparoscopic radical nephrectomy for low-stage RCC.
  • To review existing literature on the oncologic efficacy and surgical efficiency of the procedure.
  • To detail the transperitoneal surgical technique.

Main Methods:

  • Laparoscopic radical nephrectomy performed on 121 patients with clinical stage T1-T2 RCC.
  • Detailed description of the transperitoneal approach, emphasizing intact specimen removal.

Related Experiment Videos

  • Review of literature data for comparison and validation.

    • Main Results:

    • Mean operative time: 2.4 hours; Mean blood loss: 154 ml.
    • Low complication rates: 5% minor, 4% major; no conversions to open surgery.
    • Mean postoperative hospital stay: 6.1 days; no recurrence in 73 patients with 13.3 months follow-up.

    Conclusions:

    • Laparoscopic radical nephrectomy demonstrates low morbidity and high surgical efficiency for low-stage RCC.
    • Promising oncologic outcomes with low recurrence and metastasis rates, and high tumor-specific survival.
    • While long-term data is limited, laparoscopy is becoming the standard treatment for this indication.